Physician profile
Andre Samuel
NPI 1184087108
$44,448.11
in general payments reported to CMS, 2019-2025
22 companies · $26K in 2025
The $26K reported for 2025 was more than what 81% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2021: $693 · 2022: $3,018 · 2023: $6,135 · 2024: $8,651 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $19K · Consulting Fee: $15K · Food and Beverage: $6,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $19,399.70 |
| Consulting Fee | $15,000.00 |
| Food and Beverage | $6,209.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $21,509.25 | 2022-2025 | Other - Miscellaneous, Solus Alif, Battalion Plif - Ps |
| Retropsoas Technologies, LLC | $9,921.54 | 2025 | |
| Globus Medical, INC. | $3,183.42 | 2022-2024 | Elsa, Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Cerapedics INC. | $2,016.04 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Nuvasive, INC. | $1,756.85 | 2022-2023 | Xlif, Tlif |
| Medical Device Business Services, INC. | $1,145.10 | 2024 | Teligen |
| Medacta USA, INC. | $797.40 | 2025 | Myspine |
| Medinc of Texas | $793.09 | 2024-2025 | |
| Medtronic, INC. | $711.18 | 2021-2024 | Unid_pass |
| Si-Bone, INC. | $675.46 | 2021-2025 | |
| Depuy Synthes Sales INC. | $404.37 | 2022-2024 | Fibergraft Bg Morsels, X-Pac, Teligen |
| Aesculap Implant Systems, LLC | $312.58 | 2023-2024 | Ennovate, Activl |
| Providence Medical Technology, INC. | $302.77 | 2023-2025 | |
| Sanara Medtech INC. | $260.65 | 2025 | Celleraterx |
| Boston Scientific Corporation | $162.93 | 2024 | Intracept |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $127.98 | 2019 | |
| Lifenet Health | $126.53 | 2024 | Allograft Vmis Delivery System |
| Intrinsic Therapeutics | $77.85 | 2023 | Barricaid Acd (Annular Closure Device) |
| Carlsmed, INC. | $74.65 | 2024 | Aprevo |
| Becton, Dickinson and Company | $41.76 | 2023 | Arista Ah Flexitip |
| Amgen INC. | $34.22 | 2024 | Prolia, Evenity |
| Kerecis Limited | $12.49 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.